In-hospital mortality and associated factors in patients with systemic lupus erythematosus: analysis over more than 11 years in a reference hospital center
Authors:
- Michelle Arrucha-CozayaMAMichelle Arrucha-Cozaya
- Nuria Cecilia Zamora-ZúñigaNZNuria Cecilia Zamora-Zúñiga
- Dafhne Miranda-HernándezDMDafhne Miranda-Hernández
- Reyna Bustamante-GonzálezRBReyna Bustamante-González
- Gabriela Martínez-DíazGMGabriela Martínez-Díaz
- Drusila Tovar-RodríguezDTDrusila Tovar-Rodríguez
- Berenice López-ZamoraBLBerenice López-Zamora
- María Del Pilar Cruz-DomínguezMCMaría Del Pilar Cruz-Domínguez
- Abraham Edgar Gracia-RamosAGAbraham Edgar Gracia-Ramos
- Miguel Angel SaavedraMSMiguel Angel Saavedra
- 30 September 2023
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 43 (12) , 2221-2231
Abstract
Systemic lupus erythematosus (SLE) is a disease that affects the immune system, and it can lead to increased morbidity and mortality. The primary causes of mortality for individuals with SLE are disease activity, infections, drug toxicity, and other health conditions. The aim of this study is to estimate the mortality rate of patients with SLE who are hospitalized, describe the causes of death, and identify factors associated with mortality. The study was conducted at a referral hospital from 2009 to 2021, utilizing a nested case–control design. The records of patients with SLE who were hospitalized in the Department of Rheumatology were reviewed. Cases were identified as individuals who died during their hospitalization, while controls were those who were discharged alive during the same period. Elective hospitalizations were not included in the study. The primary causes of death were recorded, and demographic, clinical, laboratory, and immunological variables were analyzed as potential risk factors associated with in-hospital mortality. The study included 105 patients who died while hospitalized and 336 who were discharged alive. The estimated mortality rate was 10.93 deaths per 1000 hospital admissions per year. The leading causes of death were SLE activity (20%), infections (34.2%), or a combination of both (24.8%). Risk factors associated with in-hospital mortality were any infection (OR 2.5, CI 95% 1.2–5.2), nosocomial infections (OR 5.0, CI 95% 1.8–13.7), SLEDAI-2K > 2 (OR 2.0, CI 95% 1.02–3.8), lymphopenia (OR 2.1, CI 95% 1.01–4.6), anemia (OR 2.9, CI 95% 1.4–5.7), and thrombocytopenia (OR 3.3, CI 95% 1.7–6.4). Disease activity and infections, particularly nosocomial infections, are significant causes of mortality in hospitalized patients with SLE. Furthermore, hematological manifestations play a significant role in in-hospital mortality for these patients.Keywords
This publication has 51 references indexed in Scilit:
- Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple‐Cause‐of‐Death AnalysisArthritis & Rheumatology, 2014
- Survival in systemic lupus erythematosus, 1995–2010. A prospective study in a Danish communityLupus, 2013
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- Childhood‐onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosusArthritis Care & Research, 2010
- Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosusLupus, 2009
- Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patientsLupus, 2009
- Pathophysiology and Clinical Spectrum of Infections in Systemic Lupus ErythematosusRheumatic Disease Clinics of North America, 2009
- Causes and predictors of death in South Africans with systemic lupus erythematosusRheumatology, 2007
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- The bimodal mortality pattern of systemic lupus erythematosusThe American Journal of Medicine, 1976